Thibaut Mongon Johnson & Johnson (JNJ) insider trading activity

Thibaut Mongon is Exec VP, WW Chair, Cons Health of JOHNSON & JOHNSON. Currently has a direct ownership of 65,915 shares of JNJ, which is worth approximately $10.2 Million. The most recent transaction as insider was on Feb 13, 2023, when has been sold 6,430 shares (Common Stock) at a price of $162.01 per share, resulting in proceeds of $1,041,724. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 65.9K

0% 3M change

0% 12M change

Total Value Held $10.2 Million

Thibaut Mongon Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 13 2023	SELL Payment of exercise price or tax liability	$1,041,724 $162.01 p/Share	6,430 Reduced 8.89%	65,915 Common Stock
Feb 13 2023	BUY Grant, award, or other acquisition	-	13,710 Added 15.93%	72,345 Common Stock
Feb 10 2023	SELL Payment of exercise price or tax liability	$133,878 $162.08 p/Share	826 Reduced 1.39%	58,635 Common Stock
Feb 10 2023	BUY Exercise of conversion of derivative security	-	2,285 Added 3.7%	59,461 Common Stock
Nov 07 2022	BUY Exercise of conversion of derivative security	$1,853,767 $108.77 p/Share	17,043 Added 22.96%	57,176 Common Stock
Nov 04 2022	SELL Open market or private sale	$6,033,410 $171.18 p/Share	35,246 Reduced 46.76%	40,133 Common Stock
Nov 04 2022	BUY Exercise of conversion of derivative security	$4,607,357 $130.72 p/Share	35,246 Added 31.86%	75,379 Common Stock
Mar 17 2022	SELL Open market or private sale	$1,916,760 $176.27 p/Share	10,874 Reduced 14.56%	63,814 Common Stock
Mar 17 2022	SELL Open market or private sale	$4,174,013 $176.26 p/Share	23,681 Reduced 37.11%	40,133 Common Stock
Mar 17 2022	BUY Exercise of conversion of derivative security	$3,108,361 $100.97 p/Share	30,785 Added 29.19%	74,688 Common Stock
Feb 15 2022	SELL Payment of exercise price or tax liability	$305,735 $165.89 p/Share	1,843 Reduced 4.03%	43,903 Common Stock
Feb 15 2022	BUY Exercise of conversion of derivative security	-	3,922 Added 7.9%	45,746 Common Stock
Feb 14 2022	SELL Payment of exercise price or tax liability	$256,652 $168.85 p/Share	1,520 Reduced 3.51%	41,824 Common Stock
Feb 14 2022	BUY Exercise of conversion of derivative security	-	3,759 Added 7.98%	43,344 Common Stock
Feb 12 2021	SELL Payment of exercise price or tax liability	$558,731 $165.55 p/Share	3,375 Reduced 7.86%	39,585 Common Stock
Feb 12 2021	BUY Exercise of conversion of derivative security	-	7,145 Added 14.26%	42,960 Common Stock
Feb 21 2020	SELL Open market or private sale	$5,803,583 $147.96 p/Share	39,224 Reduced 52.27%	35,815 Common Stock
Feb 21 2020	BUY Exercise of conversion of derivative security	$1,738,619 $90.44 p/Share	19,224 Added 20.39%	75,039 Common Stock
Feb 13 2020	SELL Payment of exercise price or tax liability	$217,264 $150.46 p/Share	1,444 Reduced 2.52%	55,815 Common Stock
Feb 13 2020	BUY Exercise of conversion of derivative security	-	3,692 Added 6.06%	57,259 Common Stock

Also insider at

KVUE

Kenvue Inc.

Chief Executive Officer

Thibaut Mongon

Exec VP, WW Chair, Cons Health

New Brunswick, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JNJ shares.

Notify only if

Value

Insider Trading

Get notified when an Johnson & Johnson insider buys or sells JNJ shares.

Notify only if

Operation

Value

Type

News

Receive news related to JOHNSON & JOHNSON

Track Activities on JNJ

Account